Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1

PLoS One. 2012;7(3):e32813. doi: 10.1371/journal.pone.0032813. Epub 2012 Mar 14.

Abstract

Staphylococcus aureus initiates infections and produces virulence factors, including superantigens (SAgs), at mucosal surfaces. The SAg, Toxic Shock Syndrome Toxin-1 (TSST-1) induces cytokine secretion from epithelial cells, antigen presenting cells (APCs) and T lymphocytes, and causes toxic shock syndrome (TSS). This study investigated the mechanism of TSST-1-induced secretion of proinflammatory cytokines from human vaginal epithelial cells (HVECs) and determined if curcumin, an anti-inflammatory agent, could reduce TSST-1-mediated pathology in a rabbit vaginal model of TSS. TSST-1 caused a significant increase in NF-κB-dependent transcription in HVECs that was associated with increased expression of TNF- α, MIP-3α, IL-6 and IL-8. Curcumin, an antagonist of NF-κB-dependent transcription, inhibited IL-8 production from ex vivo porcine vaginal explants at nontoxic doses. In a rabbit model of TSS, co-administration of curcumin with TSST-1 intravaginally reduced lethality by 60% relative to 100% lethality in rabbits receiving TSST-1 alone. In addition, TNF-α was undetectable from serum or vaginal tissue of curcumin treated rabbits that survived. These data suggest that the inflammatory response induced at the mucosal surface by TSST-1 is NF-κB dependent. In addition, the ability of curcumin to prevent TSS in vivo by co-administration with TSST-1 intravaginally suggests that the vaginal mucosal proinflammatory response to TSST-1 is important in the progression of mTSS.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Toxins / toxicity*
  • Cell Line, Transformed
  • Chemokines / metabolism
  • Curcumin / pharmacology*
  • Curcumin / therapeutic use
  • Disease Models, Animal
  • Enterotoxins / toxicity*
  • Epithelial Cells / drug effects
  • Epithelial Cells / microbiology*
  • Epithelial Cells / pathology*
  • Female
  • Humans
  • In Vitro Techniques
  • Inflammation Mediators / metabolism*
  • Interleukin-8 / biosynthesis
  • Mucous Membrane / drug effects
  • Mucous Membrane / microbiology
  • Mucous Membrane / pathology
  • NF-kappa B / metabolism
  • Protective Agents / pharmacology*
  • Protective Agents / therapeutic use
  • Rabbits
  • Shock, Septic / drug therapy
  • Shock, Septic / immunology
  • Shock, Septic / microbiology
  • Shock, Septic / prevention & control
  • Signal Transduction / drug effects
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / physiology*
  • Superantigens / toxicity*
  • Sus scrofa
  • Vagina / drug effects
  • Vagina / microbiology
  • Vagina / pathology

Substances

  • Bacterial Toxins
  • Chemokines
  • Enterotoxins
  • Inflammation Mediators
  • Interleukin-8
  • NF-kappa B
  • Protective Agents
  • Superantigens
  • enterotoxin F, Staphylococcal
  • Curcumin